The DEA and FDA are currently working toward making hydrocodone-containing drugs schedule II due to abuse and high prescribing rates.This will result in no refills and limits on providers who can prescribe.

Question

Quizplus · Accepted Answer

The DEA reclassified hydrocodone combination products as Schedule II drugs in 2014 to address abuse and high prescribing rates, imposing stricter regulations on prescribing and refilling these medications.

The DEA and FDA Are Currently Working Toward Making Hydrocodone-Containing